Australian and New Zealand Paediatric Infectious Diseases Group
ANZPID strives to promote child health in the field of paediatric infectious diseases.
-
ANZPID aims to:
Advocate on issues of importance to children with infectious diseases, including, but not limited to, their inclusion in policy, guidelines and funding opportunitiesFoster and promote collaborative research among group member institutions in the field of paediatric infectious diseases.
Foster publication of scientific proceedings and other materials including reviews and clinical guidelines.
Engage with other PID societies at regular international meetings and other paediatric infectious diseases events.
ANZPID educational activities include:
An annual Clinical meetingAn ANZPID Symposia at the ASID Annual Scientific Meeting.
The popular ANZPID Journal and Quiz Club is run by ANZPID. There are no limitations to the scope of the journal club, other than relevance to paediatric infectious diseases. Multiple choice questions are submitted based on the journal club review/topic and trainees are encouraged to be the leaders of this process.
Committee:
Chair: Dr Brendan McMullan
Deputy Chair: Dr Anita Campbell
Members: Dr Archana Koirala, Dr Rachel Webb
Trainee Committee Member: Dr Li Jun Thean
ASID Clinical Research Network Committee Member: Dr Ameneh Khatami
The World Society for Pediatric Infectious Diseases (WSPID) member: Dr Phoebe Williams, Dr Linny Phuong. -
If you join ASID and ANZPID you will have access to a variety of educational webinar recordings on infection prevention and management of infections in children; as well as being able to attend clinical meetings to further your learning and development. If you're interested, you can also get involved in research and advocacy. Become a member today!
-
2023
Non-occupational post-exposure prophylaxis (nPEP)
This guideline represents a stepwise approach for managing children at risk of blood-borne infections and where relevant, sexually transmitted infections, following non-occupational exposure to body-fluids.2022
Management of Perinatal Infections
Third Edition. November 2022. Editors: Pamela Palasanthiran, Mike Starr, Cheryl Jones and Michelle Giles.2016
Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: Systematic review and guidelines June 2016. Developed by the ANZPID Australasian Stewardship of Antimicrobials in Paediatrics (ASAP). -
-
Paediatric ID sites in Australia and New Zealand
Paediatric hospitals in Australia and New Zealand welcome infectious diseases specialists or trainees to meet the infectious diseases department, observe clinical care, research and other areas of clinical interest. Hospital specific information can be found below. Please note that this is a self-funded experience and subject to visa checks and local regulations.
Australia
The Royal Children’s Hospital Melbourne, VIC
Sydney Children’s Hospital, NSW
The Children’s Hospital at Westmead, Sydney, NSW
Queensland Children’s Hospital, Brisbane, QLD
Perth Children’s Hospital, Perth, WA
New Zealand
Starship Children’s Hospital, Auckland
Christchurch children’s Hospital, Christchurch
International Paediatric Infectious Diseases Societies
European Society of Paediatric Infectious Diseases
Pediatric Infectious Diseases Society of America
Asian Society for Paediatric Infectious Diseases
Paediatric European Network for the Treatment of AIDS
-
The ANZPID-ASAP group convened in mid 2011 to:
-Act as a focus group to promote antimicrobial stewardship in children in Australia and New Zealand via leadership and the exchange of information and ideas
-Work towards a national antimicrobial stewardship program in children and advise on how this can best be achieved
-Advocate that children be included in future plans regarding national antimicrobial stewardship.
Chair: Dr Penelope Bryant
Co-chair: Dr Brendan McMullanPaediatric Antimicrobial Stewardship Good Practice Recommendations
International paediatric antimicrobial stewardship (AMS) best practice recommendations were formulated and published in 2023. See: Paediatric Antimicrobial Stewardship: Good Practice Recommendations.
These are evidence-based good practice recommendations to improve effective antimicrobial prescribing in paediatric settings, for short these are known as PAS-GPRs. Along with recommendations there are examples of good practices to assist frontline clinicians in achieving them.
Hosted by the British Society for Antimicrobial Chemotherapy it also features examples of quality improvement (QI) initiatives that have facilitated the implementation of paediatric AMS in various settings such as paediatric emergency departments, neonatal units, and paediatric intensive care units (PICUs), among others.
There is an opportunity for individuals to contribute to the sharing of best practices by submitting their QI projects established within their organisations; the submission template is available on the website, and completed forms can be submitted through it. All submissions will undergo review by the project group before being added to the website. Read more.See how the recommendations were derived.
See other examples of paediatric AMS quality improvement projects.
ANZPID-ASAP Guidelines for Antibiotic Duration and IV-Oral Switch in Children
The ANZPID-ASAP Guidelines for Antibiotic Duration and IV to Oral Switch in Children was published in 2016 and was the first guideline of its kind to provide recommendations for common bacterial infections in children.
The guideline table is also available in stand-alone format, both in the full 4 page version and in a modified 2 page version for ease of use.
You can download and make your own Lanyard using the front and back pages.
See NSW Clinical Excellence Commission resources based on these guidelines.
-
This resource is for anyone interested in paediatric infectious diseases. Journal articles are submitted by ANZPID members along with a quiz. Trainees are encouraged to participate.
Read the article and findings and then test your knowledge by taking the quiz.
-
Oct 2024
Beyond Early - and Late - onset Neonatal Sepsis Definitions. What are the Current Causes of Neonatal Sepsis Globally? A Systematic Review and Meta-analysis of the Evidence
Submitted by: Dr Krist Ewe, Dr Sam Brophy-Williams, Dr Alayne Bennett. Perth Children’s Hospital, Western Australia. Supervisor: Dr. Anita Campbell.
AccessSept 2024
Ziresovir in hospitalised infants with RSV infection
Submitted by: Robert Duguid, Royal Darwin Hospital.
Supervising consultants: Jennifer Yan, Joshua Francis, Te-Yu Hung.
AccessAug 2024
Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study.
Submitted by: Samantha Bannister and Nan Vasilunas, Women’s and Children’s Hospital, Adelaide.
AccessJuly 2024
Valganciclovir in Infants with Hearing Loss and Clinically Inapparent Congenital Cytomegalovirus Infection: A Nonrandomized Controlled Trial.
Submitted by: Dr Eloise Silvester, Paediatric Infectious Diseases Advanced Trainee Registrar & Supervising consultant Dr Jeremy Carr; Monash Children’s Hospital, Melbourne Vic.
AccessJune 2024
Efficacy and safety of withholding antimicrobial therapy in children with cancer, fever, and neutropenia, with a demonstrated viral respiratory infection: a randomized clinical trial
Submitted by: Dr Rachel Heenan, Dr Shu Ki Tsoi, Dr Nelson Wang, Prof Nigel Curtis; The Royal Children’s Hospital, Melbourne, June 2024.
AccessMay 2024
Practice Versus Potential: The Impact of the BioFire FilmArray Pneumonia Panel on Antibiotic Use in Children.
Submitted by: Dr Anya Stephenson Wellington Regional Hospital, New Zealand
Read more
There is no quiz for this journal article.April 2024
Predictors of the Outcome at 2 years in Neonates with Congenital Cytomegalovirus Infection.
Submitted by: Dr Rebecca Ward, Dr Julia Clark & Dr Angela Berkhout, Queensland Children’s Hospital.
AccessMarch 2024
Short oral antibiotic therapy for pediatric febrile urinary tract infections: A randomized controlled trial
Submitted by: Dr Tony Walls, Christchurch Hospital, HealthNZ.
Read more
There is no quiz for this journal article.February 2024
Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants.
Submitted by: Niall Johnston and Brendan McMullan, Sydney Children’s Hospital, NSW.
AccessJanuary 2024
Malaria Transmission Intensity Likely Modifies RTS, S/AS01 Efficacy Due to a Rebound Effect in Ghana, Malawi, and Gabon.
Submitted by: Geoffrey Guenther MD, Boston Children’s Hospital, Boston, MA, USA.
Access -
November 2023
Probiotic for pathogen-specific Staphylococcus aureus decolonisation in Thailand: a phase 2, double-blind, randomised, placebo-controlled trial.
Submitted by: Dr Nerida Moore, Perth Children’s Hospital, WA.
AccessNirsevimab for Prevention of RSV in Term and Late-Preterm Infants.
Submitted by: Dr. Laila Al Yazidi, Senior Consultant, Sultan Qaboos University Hospital, Muscat, Oman.
AccessAntibiotic Prophylaxis in Infants with Grade III, IV, or V Vesicoureteral Reflux.
Submitted by: Dr Akshatha Ravindra MD, DNB. Senior Resident (Infectious Diseases) Division of Infectious Diseases. Department of Medicine. AIIMS Jodhpur.
AccessOctober 2023
Nutritional supplementation to prevent tuberculosis incidence in household contacts of patients with pulmonary tuberculosis in India (RATIONS): a field-based, open label, cluster-randomised, controlled trial
Submitted by: Dr Meghan Gunst, Paediatric Infectious Diseases Trainee, Associate Professor Josh Francis, Dr Jennifer Yan and Dr Te-Yu Hung, Royal Darwin Hospital, Northern Territory.
AccessStructured Structured Immune Workup in Healthy Children With a First Episode of Severe Bacterial Infection: A 7-year Single-Centre StudyImmune Workup in Healthy Children With a First Episode of Severe Bacterial Infection: A 7-year Single-Centre Study
Submitted by: Dr Sarah Allen and Dr Celia Cooper.
AccessJuly 2023
Treatment Strategy for Rifampin-Susceptible Tuberculosis.
Submitted by: Dr Nelson Wang. Supported by Dr Jeremy Carr.
AccessJune 2023
Revised Protocol for Secondary Prevention of Congenital Cytomegalovirus Infection with Valaciclovir Following Infection in Early Pregnancy.
Submitted by: Dr Shu Ki Tsoi, Dr Alison Boast, Dr Natalie Yap, Prof Nigel Curtis.
AccessNeonatal Herpes Simplex Virus: Cutaneous Recurrence Is Common on Stopping Prophylactic Suppression Therapy.
Submitted by: Dr Mohamed Tashani and Assoc Prof Pamela Palasanthiran.
AccessMay 2023
The Clinical Utility of MRSA Nasal Surveillance Swabs in Ruling-Out MRSA Infections in Children.
Submitted by: Dr Emma Best, Dr Rachel Webb, Michael-John Fay.
AccessClimate Change and Vectorborne Diseases.
Submitted by: Dr Kristen Bastug
AccessApril 2023
Adeno-associated virus 2 infection in children with non-A-E hepatitis. Submitted by: Associate Professor Julia Clark and Dr Robyn Silcock.
AccessMarch 2023
Spontaneous clearance of vertically acquired Hepatitis C infection: Implications for testing and treatment.
Submitted by: Professor Tony Walls
Access -
Check out the articles and quiz questions from 2022.
Access -
Check out the articles and quiz questions from 2021.
Access -
Check out the articles and quiz questions from 2020.
Access -
Check out the articles and quiz questions from 2019.
Access -
Check out the articles and quiz questions from 2018.
Access
